574
Views
5
CrossRef citations to date
0
Altmetric
Research Articles

Investigation of in vitro and in silico effects of some novel carbazole Schiff bases on human carbonic anhydrase isoforms I and II

ORCID Icon, ORCID Icon, ORCID Icon, ORCID Icon & ORCID Icon
Pages 6965-6973 | Received 10 Aug 2020, Accepted 15 Feb 2021, Published online: 01 Mar 2021

References

  • Adem, S., Akkemik, E., Aksit, H., Guller, P., Tüfekci, A. R., Demirtas, İ., & Ciftci, M. (2019). Activation and inhibition effects of some natural products on human cytosolic CAI and CAII. Medicinal Chemistry Research, 28(5), 711–722. https://doi.org/10.1007/s00044-019-02329-1
  • Akkemik, E., Cicek, B., Camadan, Y., Calisir, U., & Onbasioglu, Z. (2018). The determination of the carbonic anhydrases activators in vitro effect of mixed donor crown ethers. Journal of Biochemical and Molecular Toxicology, 32(3), e22032. https://doi.org/10.1002/jbt.22032
  • Aktas, A., Taslimi, P., Gülçin, İ., & Gök, Y. (2017). Novel NHC precursors: Synthesis, characterization, and carbonic anhydrase and acetylcholinesterase inhibitory properties. Archiv Der Pharmazie, 350, 1–11. https://doi.org/10.1002/ardp.201700045
  • Alım, Z., Kılınç, N., İşgör, M. M., Şengül, B., & Beydemir, Ş. (2015). Some anti-inflammatory agents inhibit esterase activities of human carbonic anhydrase isoforms I and II: An in vitro study. Chemical Biology & Drug Design, 86(4), 857–863. https://doi.org/10.1111/cbdd.12561
  • Altintop, M. D., Ozdemir, A., Kucukoglu, K., Turan-Zitouni, G., Nadaroglu, H., & Kaplancikli, Z. A. (2015). Synthesis and evaluation of new thiadiazole derivatives as potential inhibitors of human carbonic anhydrase isozymes (hCA-I and hCA-II). Journal of Enzyme Inhibition and Medicinal Chemistry, 30(1), 32–37. https://doi.org/10.3109/14756366.2013.873038
  • Angapelly, S., Ramya, P. V. S., Angeli, A., Monti, S. M., Buonanno, M., Alvala, M., Supuran, C. T., & Arifuddin, M. (2017). Discovery of 4-sulfamoyl-phenyl-β-lactams as a new class of potent carbonic anhydrase isoforms I, II, IV and VII inhibitors: The first example of subnanomolar CA IV inhibitors. Bioorganic & Medicinal Chemistry, 25(2), 539–544. https://doi.org/10.1016/j.bmc.2016.11.027
  • Angeli, A., Ferraroni, M., & Supuran, C. T. (2018). Famotidine, an antiulcer agent, strongly inhibits Helicobacter pylori and human carbonic anhydrases. ACS Medicinal Chemistry Letters, 9(10), 1035–1038. https://doi.org/10.1021/acsmedchemlett.8b00334
  • Armstrong, J. M., Myers, D. V., Verpoorte, J. A., & Edsall, J. T. (1966). Purification and properties of human erythrocyte carbonic anhydrases. The Journal of Biological Chemistry, 241(21), 5137–5149.
  • Balaydin, H. T., Durdaği, S., Ekinci, D., Sentürk, M., Göksu, S., & Menzek, A. (2012). Inhibition of human carbonic anhydrase isozymes I, II and VI with a series of bisphenol, methoxy and bromophenol compounds. Journal of Enzyme Inhibition and Medicinal Chemistry, 27(4), 467–475. https://doi.org/10.3109/14756366.2011.596836
  • Bandgar, P. A., Adsul, K. L., Chavan, H. V., Jalde, S. S., Shringare, S. N., Shaikh, R., Meshram, R. J., Gacche, NR., & Masand, V. (2012). Synthesis, biological evaluation, and docking studies of 3-(substituted)-aryl-5-(9-methyl-3-carbazole)-1H-2-pyrazolines as potent anti-inflammatory and antioxidant agents. Bioorganic & Medicinal Chemistry Letters, 22(18), 5839–5844. https://doi.org/10.1016/j.bmcl.2012.07.080
  • Bashir, M., Bano, A., Ijaz, A. S., & Chaudhary, B. A. (2015). Recent developments and biological activities of N-substituted carbazole derivatives: A review. Molecules (Basel, Switzerland), 20(8), 13496–13517. https://doi.org/10.3390/molecules200813496
  • Beydemir, S., CIftçi, M., Ozmen, I., Buyukokuroğlu, M. E., Ozdemir, H., & Küfrevioglu, O. I. (2000). Effects of some medical drugs on enzyme activities of carbonic anhydrase from human erythrocytes in vitro and from rat erythrocytes in vivo. Pharmacological Research, 42(2), 187–191. https://doi.org/10.1006/phrs.2000.0674
  • Botta, A., Venditto, V., Rubino, A., & Pragliola, S. (2016). Highly isotactic poly(N-butenyl-carbazole): Synthesis, characterization, and optical properties. Journal of Chemistry, 2016, 1–8. https://doi.org/10.1155/2016/1656459
  • Bouaziz, Z., Issa, S., Gentili, J., Gratz, A., Bollacke, A., Kassack, M., Jose, J., Herfindal, L., Gausdal, G., Døskeland, O. S., Mullie ́, C., Sonnet, P., Desgrouas, C., Taudon, N., Valdameri, G., Pietro, D. A., Baitiche, M., & Borgne, L. M. (2015). Biologically active carbazole derivatives: Focus on oxazinocarbazoles and related compounds. Journal of Enzyme Inhibition and Medicinal Chemistry, 30, 180–188.
  • Boztaş, M., Çetinkaya, Y., Topal, M., Gülçin, İ., Menzek, A., Şahin, E., Tanc, M., & Supuran, C. T. (2015). Synthesis and carbonic anhydrase isoenzymes I, II, IX, and XII inhibitory effects of dimethoxybromophenol derivatives incorporating cyclopropane moieties. Journal of Medicinal Chemistry, 58(2), 640–650. https://doi.org/10.1021/jm501573b
  • Bradford, M. M. (1976). Rapid and sensitive method for quantitation of microgram quantities of protein utilizing principle of protein-dye binding. Analytical Biochemistry, 72(1–2), 248–254. https://doi.org/10.1016/0003-2697(76)90527-3
  • Camadan, Y., Cicek, B., Calısır, U., & Akkemik, E. (2016). Investigation of the inhibitory effects some Schiff bases on isozymes hCA I and hCA II purified from human erythrocytes, oral presentation. 4th International Bau Drug Design Congress, 13–15 October 2016.
  • Caruso, A., Lancelot, C. J., Kashef, E. H., Panno, A., Sinicropi, S. M., Legay, R., Lesnard, A., Lepailleur, A., & Rault, S. (2014). Four partners, three-step, one-pot reaction for a library of new 2-alkyl (dialkyl)aminoquinazolin-4(3H)-ones. Journal of Heterocyclic Chemistry, 51(S1), E282–E293. https://doi.org/10.1002/jhet.1942
  • Chakrabarty, M., Ghosh, N., & Harigaya, Y. (2004). A clay-mediated, regioselective synthesis of 2-(aryl/alkyl)amino-thiazolo[4,5-c]carbazoles. Tetrahedron Letters, 45(25), 4955–4957. https://doi.org/10.1016/j.tetlet.2004.04.129
  • Çiçek, B., Çalışır, Ü., Tavaslı, M., Tülek, R., & Teke, A. (2018). Synthesis and optical characterization of novel carbazole Schiff bases. Journal of Molecular Structure, 1153, 42–47. https://doi.org/10.1016/j.molstruc.2017.09.109
  • Daina, A., Michielin, O., & Zoete, V. (2017). SwissADME: A free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Scientific Reports, 7, 42717. https://doi.org/10.1038/srep42717
  • Del Prete, S., Vullo, D., De Luca, V., Carginale, V., di Fonzo, P., Osman, S. M., AlOthman, Z., Supuran, C. T., & Capasso, C. (2016). Anion inhibition profiles of α-, β- and γ-carbonic anhydrases from the pathogenic bacterium Vibrio cholerae. Bioorganic & Medicinal Chemistry, 24(16), 3413–3417. https://doi.org/10.1016/j.bmc.2016.05.029
  • Di, L. (2014). The role of drug metabolizing enzymes in clearance. Expert Opinion on Drug Metabolism & Toxicology, 10(3), 379–393. https://doi.org/10.1517/17425255.2014.876006
  • Dodgson, S. J., Shank, R. P., & Maryanoff, B. E. (2000). Topiramate as an inhibitor of carbonic anhydrase isoenzymes. Epilepsia, 41(S1), 35–S39. https://doi.org/10.1111/j.1528-1157.2000.tb06047.x
  • Durdagi, S., Şentürk, M., Ekinci, D., Balaydın, H. T., Göksu, S., Küfrevioğlu, Ö. İ., Innocenti, A., Scozzafava, A., & Supuran, C. T. (2011). Kinetic and docking studies of phenol-based inhibitors of carbonic anhydrase isoforms I, II, IX and XII evidence a new binding mode within the enzyme active site. Bioorganic & Medicinal Chemistry, 19(4), 1381–1389. https://doi.org/10.1016/j.bmc.2011.01.016
  • Egan, W. J., Merz, K. M., & Baldwin, J. J. (2000). Prediction of drug absorption using multivariate statistics. Journal of Medicinal Chemistry, 43(21), 3867–3877. https://doi.org/10.1021/jm000292e
  • Ekinci, D., Beydemir, S., & Küfrevioğlu, Ö. İ. (2007). In vitro inhibitory effects of some heavy metals on human erythrocyte carbonic anhydrases. Journal of Enzyme Inhibition and Medicinal Chemistry, 22(6), 745–750. https://doi.org/10.1080/14756360601176048
  • Ghose, A. K., Viswanadhan, V. N., & Wendoloski, J. J. (1999). A knowledge-based approach in designing combinatorial or medicinal chemistry libraries for drug discovery. 1. A qualitative and quantitative characterization of known drug databases. Journal of Combinatorial Chemistry, 1(1), 55–68. https://doi.org/10.1021/cc9800071
  • Guller, P., Karaman, M., GüLler, U., Aksoy, M., & KüFrevioğlu, Ö. İ., (2020). A study on the effects of inhibition mechanism of curcumin, quercetin, and resveratrol on human glutathione reductase through in vitro and in silico approaches. Journal of Biomolecular Structure and Dynamics. https://doi.org/10.1080/07391102.2020.1738962
  • Hollenberg, P. F. (2002). Characteristics and common properties of inhibitors, inducers, and activators of CYP enzymes. Drug Metabolism Reviews, 34(1–2), 17–35. https://doi.org/10.1081/dmr-120001387
  • Indumathi, T., Fronczek, R. F., & Prasad, K. J. R. (2012). Synthesis of 2-amino-8-chloro-4-phenyl-5,11-dihydro-6H-pyrido[2,3-a]carbazole-3-carbonitrile: Structural and biological evaluation. Journal of Molecular Structure, 1016, 134–139. https://doi.org/10.1016/j.molstruc.2012.01.032
  • Kaplancikli, Z. A. (2011). Synthesis of some novel carbazole derivatives and evaluation of their antimicrobial activity. Marmara Pharmaceutcal Journal, 3(15), 105–109. https://doi.org/10.12991/201115426
  • Laemmli, U. K. (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature, 227(5259), 680–685. https://doi.org/10.1038/227680a0
  • Lipinski, C. A., Lombardo, F., Dominy, B. W., & Feeney, P. J. (1997). Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Advanced Drug Delivery Reviews, 23(1–3), 3–25. https://doi.org/10.1016/S0169-409X(96)00423-1
  • Lomelino, C. L., Supuran, C. T., & McKenna, R. (2016). Non-classical inhibition of carbonic anhydrase. International Journal of Molecular Sciences, 17(7), 1150–1113. https://doi.org/10.3390/ijms17071150
  • Mader, P., Brynda, J., Gitto, R., Agnello, S., Pachl, P., Supuran, C. T., Chimirri, A., & Řezáčová, P. (2011). Structural basis for the interaction between carbonic anhydrase and 1,2,3,4-tetrahydroisoquinolin-2-ylsulfonamides. Journal of Medicinal Chemistry, 54(7), 2522–2526. https://doi.org/10.1021/jm2000213
  • Maren, T. H. (1987). Carbonic anhydrase: General perspective and advances in glaucoma research. Drug Development Research, 10(4), 255–276. https://doi.org/10.1002/ddr.430100407
  • Muegge, I., Heald, S. L., & Brittelli, D. (2001). Simple selection criteria for drug-like chemical matter. Journal of Medicinal Chemistry, 44(12), 1841–1846. https://doi.org/10.1021/jm015507e
  • Nasr, G., Cristian, A., Barboiu, M., Vullo, D., Winum, J. Y., & Supuran, C. T. (2014). Carbonic anhydrase inhibitors. Inhibition of human cytosolic isoforms I and II with (reduced) Schiff's bases incorporating sulfonamide, carboxylate and carboxymethyl moieties. Bioorganic & Medicinal Chemistry, 22(10), 2867–2874. https://doi.org/10.1016/j.bmc.2014.03.041
  • Puccetti, L., Fasolis, G., Vullo, D., Chohan, Z. H., Scozzafava, A., & Supuran, C. T. (2005). Carbonic anhydrase inhibitors. Inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, IX, and XII with Schiff's bases incorporating chromone and aromatic sulfonamide moieties, and their zinc complexes. Bioorganic & Medicinal Chemistry Letters, 15(12), 3096–3101. https://doi.org/10.1016/j.bmcl.2005.04.055
  • Sarikaya, B., Ceruso, M., Carta, F., & Supuran, C. T. (2014). Inhibition of carbonic anhydrase isoforms I, II, IX and XII with novel Schiff bases: Identification of selective inhibitors for the tumor-associated isoforms over the cytosolic ones. Bioorganic & Medicinal Chemistry, 22(21), 5883–5890. https://doi.org/10.1016/j.bmc.2014.09.021
  • Sarioglu, N., Bilen, C., Sackes, Z., & Gencer, N. (2015). The effects of bronchodilator drugs and antibiotics used for respiratory infection on human erythrocyte carbonic anhydrase I and II isozymes. Archives of Physiology and Biochemistry, 121(2), 56–61. https://doi.org/10.3109/13813455.2015.1011068
  • Saturnino, C., Iacopetta, D., Sinicropi, S. M., Rosano, C., Caruso, A., Caporale, A., Marra, N., Marengo, B., Pronzato, A. M., Parisi, I. O., Longo, P., & Ricciarelli, R. (2014). N-alkyl carbazole derivatives as new tools for Alzheimer's disease: Preliminary studies. Molecules (Basel, Switzerland), 19(7), 9307–9317. https://doi.org/10.3390/molecules19079307
  • Shepard, N. A., & Ticknor, A. A. (1916). Researches on amines. The formation of Schiff bases from Β-phenylethylamine and their reduction to alkyl derivatives of this amine. Journal of the American Chemical Society, 38(2), 381–387. https://doi.org/10.1021/ja02259a023
  • Singasane, N., Kharkar, P. S., Ceruso, M., Supuran, C. T., & Toraskar, M. P. (2015). Inhibition of carbonic anhydrase isoforms I, II, IX and XII with Schiff's bases incorporating iminoureido moieties. Journal of Enzyme Inhibition and Medicinal Chemistry, 30(6), 901–907. https://doi.org/10.3109/14756366.2014.986118
  • Smirnovienė, J., Smirnovas, V., & Matulis, D. (2017). Picomolar inhibitors of carbonic anhydrase: Importance of inhibition and binding assays. Analytical Biochemistry, 522, 61–72. https://doi.org/10.1016/j.ab.2017.01.022
  • Soltani Rad, M. N., Behrouz, S., & Ahrari, S. (2016). Regioselective ring-opening of epoxides by carbazole: A direct preparation of novel N-(β-hydroxyalkyl)carbazoles. Journal of Chemical Research, 40(3), 137–140. https://doi.org/10.3184/174751916X14538054606043
  • Sriyab, S., Gleeson, M. P., Hannongbua, S., & Suramitr, S. (2016). Photophysical properties and computational investigation on substituent effects on the structural and electronic properties of 3,6-di(thiophene-2-yl)-carbazole-based derivatives. Journal of Molecular Structure, 1125, 532–539. https://doi.org/10.1016/j.molstruc.2016.07.031
  • Supuran, C. T. (2010). Carbonic anhydrase inhibitors. Bioorganic & Medicinal Chemistry Letters, 20(12), 3467–3474. https://doi.org/10.1016/j.bmcl.2010.05.009
  • Supuran, C. T. (2016). Structure and function of carbonic anhydrases. The Biochemical Journal, 473(14), 2023–2032. https://doi.org/10.1042/BCJ20160115
  • Supuran, C. T. (2011). Carbonic anhydrase inhibitors and activators for novel therapeutic applications. Future Medicinal Chemistry, 3(9), 1165–1180. https://doi.org/10.4155/fmc.11.69
  • Supuran, C. T. (2012). Structure-based drug discovery of carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry, 27(6), 759–772. https://doi.org/10.3109/14756366.2012.672983
  • Takaya, Y., Tasaka, H., Chiba, T., Uwai, K., Tanitsu, M., Kim, H. S., Wataya, Y., Miura, M., Takeshita, M., & Oshima, Y. (1999). New type of febrifugine analogues, bearing a quinolizidine moiety, show potent antimalarial activity against plasmodium malaria parasite. Journal of Medicinal Chemistry, 42(16), 3163–3166. https://doi.org/10.1021/jm990131e
  • Teleb, S. M., Sadeek, S. A., & Nour, E. M. (1993). Synthesis and vibrational studies of oxovanadium (IV)-tetradentate Schiff base complexes. Spectroscopy Letters, 26(1), 169–178. https://doi.org/10.1080/00387019308011523
  • Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/10.1002/jcc.21334
  • Ul-Hassan, M., Chohan, Z. H., Scozzafava, A., & Supuran, C. T. (2004). Carbonic anhydrase inhibitors: Schiff's bases of aromatic and heterocyclic sulfonamides and their metal complexes. Journal of Enzyme Inhibition and Medicinal Chemistry, 19, 263–267. https://doi.org/10.1080/14756360410001689595
  • Veber, D. F., Johnson, S. R., Cheng, H. Y., Smith, B. R., Ward, K. W., & Kopple, K. D. (2002). Molecular properties that influence the oral bioavailability of drug candidates. Journal of Medicinal Chemistry, 45(12), 2615–2623. https://doi.org/10.1021/jm020017n
  • Verpoorte, J. A., Mehta, S., & Edsall, J. T. (1967). Esterase activities of human carbonic anhydrases B and C. Journal of Biological Chemistry, 242(18), 4221–4229. https://doi.org/10.1016/S0021-9258(18)95800-X
  • Wolfensberger, T. J. (1999). The role of carbonic anhydrase inhibitors in the management of macular edema. Documenta Ophthalmologica, 97, 183–193. https://doi.org/10.1023/A:1002143802926
  • Wulf, N. R., & Matuszewski, K. A. (2013). Sulfonamide cross-reactivity: Is there evidence to support broad cross-allergenicity? American Journal of Health-System Pharmacy, 70(17), 1483–1494. https://doi.org/10.2146/ajhp120291
  • Yıldırım, A., Atmaca, U., Keskin, A., Topal, M., Çelik, M., Gülçin, İ., & Supuran, C. T. (2015). N-acylsulfonamides strongly inhibit human carbonic anhydrase isoenzymes I and II. Bioorganic & Medicinal Chemistry, 23(10), 2598–2605. https://doi.org/10.1016/j.bmc.2014.12.054
  • Zishen, W., Ziqi, G., & Zhenhuan, Y. (1990). Synthesis, characterization and anticancer activity of L-alanine Schiff base complexes of copper(II), zinc(II), nickel(II) and cobalt(II). Synthesis and Reactivity in Inorganic and Metal-Organic Chemistry, 20(3), 335–344. https://doi.org/10.1080/00945719008048138
  • Żołnowska, B., Sławiński, J., Pogorzelska, A., Chojnacki, J., Vullo, D., & Supuran, C. T. (2014). Carbonic anhydrase inhibitors. Synthesis, and molecular structure of novel series N-substituted N'-(2-arylmethylthio-4-chloro-5-methylbenzenesulfonyl)guanidines and their inhibition of human cytosolic isozymes I and II and the transmembrane tumor-associated isozymes IX and XII. European Journal of Medicinal Chemistry, 71, 135–147. https://doi.org/10.1016/j.ejmech.2013.10.081

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.